Clinical evidence Somatotropic

Sermorelina

GHRH analogue (fragment 1-29)

GHRH fragment historically used in GH diagnosis.

Back to technical sheets
Class
GHRH analogue (fragment 1-29)
Also known as
Historic use as a GH reserve diagnostic test

Mechanism of action

Active fragment (1-29) of GHRH that stimulates pituitary GH secretion. It was used as a stimulation test to assess growth-hormone reserve.

Evidence

Clinical evidence

Historically approved for diagnostic purposes; the original product was withdrawn in some markets. Evidence for other uses is limited.

Studied uses

  • GH reserve diagnostic test (historic use)

Safety considerations

  • Injection-site reactions
  • Requires endocrine supervision
  • Availability and regulatory status vary by country

Batch quality data

We publish these figures because they are the ones the program itself teaches you to ask for.

Purity
≥ 98 % (HPLC)
Net content
82 %
Batch
SER-2601
Presentation
Polvo liofilizado en vial sellado

Net content is the fraction of the vial’s weight that is actually peptide, after discounting water, salts and excipients. It is the figure to calculate with, not the label weight.

5 mg MX$1,120 per vial

Sample prices and batch data while the real ones are loaded.

Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.